Close

Stay informed

Drop us your email and we’ll keep you up-to-date on Medicaid issues.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Letter ·

NAMD Recommends Changes to Substance Use Data Privacy Rules

On October 25, 2019, NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) regarding a proposed rule that would streamline privacy regulations for substance use disorder patient information.

Patient data related to substance use disorder (SUD) is subject to a number of privacy regulations, including 42 CFR Part 2 and HIPAA. Although these regulations were intended to protect patient privacy, they have greatly restricted the ability of providers to deliver integrated and coordinated care. In this letter, NAMD recommended that SAMHSA more closely align Part 2 rules with HIPAA to help ensure that individuals with SUD receive effective, evidence-based treatment and integrated care coordination.

Related resources

Stay Informed

Drop us your email and we’ll keep you up-to-date on Medicaid issues.